| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,600 | 0.00 | 8,766 |
| 2 Jan 25 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.93 | 7,800 | 132.05 k | 7,800 |
| 2 Jan 24 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 178,000 | 0.00 | 185,000 |
| 2 Jan 24 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6552 | 228,000 | 149.39 k | 228,000 |
| 13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.93 | 75,000 | 69.75 k | 0 |
| 13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.31 | 40,000 | 132.40 k | 0 |
| 13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.57 | 80,000 | 365.60 k | 0 |
